Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of SHP2 inhibition on hepatic stellate cell transcriptome.

ABSTRACT: Effect of SHP2 inhibition on hepatic stellate cell transcriptome.

PROVIDER: PRJNA588282 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10417430_1.fastq.gz	Fastqsanger.gz
	SRR10417430_2.fastq.gz	Fastqsanger.gz
	SRR10417431_1.fastq.gz	Fastqsanger.gz
	SRR10417431_2.fastq.gz	Fastqsanger.gz
	SRR10417432_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Effect of SHP2 inhibition on hepatic stellate cell transcriptome.

Project description:Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. Primary human hepatic stellate cells were treated with PDGF or PDGF + SHP2 inhibitor. RNA was purified and submitted for sequencing to Mayo Clinic Genomics Core. After applying the filters FDR>0.05, Log2(FC)>1 and RPKM>15, we ended up with nearly 300 genes differentially regulated between the two conditions. Ingenuity Pathway Analysis revealed that Ostheoarthritis was the first pathway to be differentially regulated. From this pathway, REDD1 (DDIT4 transcript), an mTOR inhibitor, was further explored, especially in the context of extracellular vesicle release.

2019-11-08 | GSE140110 | GEO

Effect of SHP2 Inhibition on mRNA Expression Profiles of GIST Cells

Project description:Secondary mutation of KIT/PDGFRA is the main reason that contributes to the multi-drug resistance phenotype of advanced GIST in the clinical setting. SHP2 is a specific signal transducer of KIT. Therefore, the combination of approved KIT/PDGFRA kinase inhibitors and SHP2 inhibitors is a promising treatment strategy for advanced GIST patients. Here, we treated GIST cells with the SHP2 inhibitor SHP099 and sequenced the total mRNA to analyze the effect of SHP2 inhibition on GIST cells.

2024-11-30 | GSE282434 | GEO

Hepatic Stellate Cells inhibition induced by YAP deletion

Project description:Hepatic Stellate Cells inhibition induced by YAP deletion

| PRJNA873694 | ENA

Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis

Project description:We report the effect of TGFβ vs PDGF 2h treatment in hepatic stellate cells. We also report the effect of TGFβ treatment for 48h in human hepatic stellate cells.

2018-09-07 | GSE119606 | GEO

Effect of glycolysis on hepatic stellate cell transcriptome

Project description:Effect of glycolysis on hepatic stellate cell transcriptome

| PRJNA1088561 | ENA

Effect of OGT inhibition on the epigenome of human LX-2 hepatic stellate cells

Project description:Effect of OGT inhibition on the epigenome of human LX-2 hepatic stellate cells

| PRJNA1016369 | ENA

TLR4 or CD44 deficiency effect on hepatic stellate cells

Project description:Analysis of hepatic stellate cells isoltaed from wild-type, TLR4-/-, and CD44-/- mice. TLR4 and CD44 are major hyaluronic acid receptors. Results provide insight into the effects of TLR4 and CD44 loss in hepatic stellate cells.

2020-01-01 | GSE109200 | GEO

Early Mouse Hepatic Stellate Cell Activation

Project description:Early during culture of primary mouse HSCs gene expression changes. These expression alterations can be affected by treating cells with histone deacetylase inhibitor, valproic acid Primary mouse Hepatic stellate cells were cultured for short periods of time (4-16-64h) in presence or absence of valproic acid. Gene expression analysis (mouse Gene 1.0 ST arrays according to manufacturerM-bM-^@M-^Ys manual 701880Rev4 (Affymetrix, Santa Clara, CA)), in vitro stellate cell activation and inhibition of the activation by valproic acid treatment.

2014-01-01 | E-GEOD-51882 | biostudies-arrayexpress

Hepatic Stellate Cells inhibition induced by YAP deletion

Project description:Gene expression by bulk RNAseq in isolated mouse Hepatic Stellate Cells (HSC) YAP ko compared to HSC YAP floxed (wt).

2022-08-26 | GSE212042 | GEO

TLR4 or CD44 deficiency effect on hepatic stellate cells

Project description:TLR4 or CD44 deficiency effect on hepatic stellate cells

| PRJNA430098 | ENA